Filter the full library of peptide research pages by evidence tier, risk profile, and mechanism — before you spend money on a protocol or trust a vendor claim.
Every entry links to the full research or guide page. Sort by evidence strength (strongest human data first), name, or risk. Use the filter to see only the tier you care about.
Looking for a categorized catalog instead? The /research hub lists every deep-dive, comparison, guide, and regulatory entry in one page.
Want a weekly summary? The Peptide Evidence Digest delivers FDA actions, compounding updates, and new research for these peptides every week — free.
Get the free Peptide Therapy Decision Checklist + the Decoder Kit drip — 4 research-literacy emails over 4 days. No spam. Unsubscribe anytime.
GLP-1 receptor agonist; slows gastric emptying, amplifies insulin release in response to glucose. Only peptide class with strong human RCT evidence for weight loss and glycemic control in non-diabetic adults.
"Body Protection Compound"; rodent GI and tendon-healing data dominates the literature. Zero completed RCTs as of 2026; long-term human safety profile unknown.
Standalone evidence-critique page for BPC-157: mechanism, animal-evidence landscape, zero human RCTs, Sikiric lab COI disclosure, and 2025–2026 media coverage. Deeper than the guide page.
Copper-binding tripeptide; collagen synthesis and wound healing support. Topical evidence rests on a handful of small RCTs (Finkley 2007, Pickart) — moderate tier, not strong.
Two-column evidence breakdown: topical moderate (real data behind cosmetic claims) vs injectable unproven (no human RCTs). Includes 2012 Lorentic RCT details and anti-aging claims analysis.
Standalone /peptide/ghk-cu reference page — same peptide framed for cross-comparison navigation with TB-500, BPC-157, and growth-hormone secretagogues.
Actin-binding peptide; cell migration and angiogenesis in animal models. Orphan-drug status for corneal repair; otherwise no FDA approval and WADA-prohibited.
Ghrelin-receptor agonist that triggers a pulsed GH release; often stacked with CJC-1295 (a GHRH analogue). Limited human RCTs; dosing and long-term safety unvalidated. WADA-prohibited (S2).
Synthetic GHRH 1–29 analog; amplifies endogenous GH pulse architecture via GHRH receptor. Pediatric diagnostic-stim-test only on label; no adult efficacy RCTs. WADA-prohibited (S2).
Triple agonist (GIP / GLP-1 / glucagon); Phase II results show ~24% weight loss. Hype consistently outpaces evidence: no PeptideDecoded standalone page yet — coverage lives in the microdosing article and comparison table.
Synthetic nootropic / anxiolytic peptides; most human data comes from Russian-language literature with limited independent replication. No FDA approval; sold via gray-market channels.
Full WADA 2026 prohibited-peptide list, broken down by S-category (S0 = at all times, S2 = hormones, etc.) for athletes subject to testing. Compliance reference, not a peptide page itself.
Quality / vendor red-flag checklist for anyone considering buying research-use-only peptides. Walks through cGMP, COA verification, third-party testing, and the questions every vendor should answer.
Methodology page for evaluating peptide claims yourself: evidence hierarchy, PubMed search strategy, red flags, peer review, COI checks, and a 5-question pre-purchase checklist.
FDA-approved vs compounded (503A / 503B), July 2026 reclassification context, import regulations, quality tiers, side effects, and a vendor evaluation guide.
Single-question research FAQ targeting "Is BPC-157 backed by human studies?" Evidence hierarchy table, GI / musculoskeletal data split, and honest verdict.
Standalone FAQ: what does "research use only" mean legally? Covers FDA drug vs supplement vs compounding exclusion, cGMP / inspection / approval, LegitScript compliance patterns, and what buyers should verify.
Side-by-side peptide reference table covering primary use case, human evidence tier, animal evidence tier, FDA status, WADA status, and risk profile. Quick lookup for buyer qualification.
How PeptideDecoded writes peptide content: editorial standards, evidence hierarchy, research process, conflict-of-interest policy, legal disclaimer, and corrections process.
An 8-module research-literacy kit built for anyone buying, evaluating, or following peptide protocols. Reads PubMed, flags COI, decodes vendor copy, and resists marketing tricks before you spend money.
This is a research summary dashboard, not medical advice. PeptideDecoded does not sell peptides, recommend vendors, provide dosing protocols, or make claims about safety or efficacy for any specific individual.
Work with a qualified physician who can evaluate your full medical history, current medications, and individual risk factors before making any decision about peptides — whether FDA-approved, compounded, or sold as research chemicals.